Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.
Acker G, Piper SK, Datwyler AL, Broggini T, Kremenetskaia I, Nieminen-Kelhä M, Lips J, Harms U, Mueller S, Lättig-Tünnemann G, Trachsel E, Palumbo A, Neri D, Klohs J, Endres M, Vajkoczy P, Harms C, Czabanka M.
Acker G, et al. Among authors: broggini t.
Oncotarget. 2018 Jun 12;9(45):27760-27772. doi: 10.18632/oncotarget.25570. eCollection 2018 Jun 12.
Oncotarget. 2018.
PMID: 29963235
Free PMC article.